Immunoglobulin G Fc receptor deficiency prevents Alzheimer-like pathology and cognitive impairment in mice

Brain

Volumn 135, Issue 9, 2012, Pages 2826-2837

  Fernandez Vizarra, Paula ^a,b   Lopez Franco, Oscar ^a   Mallavia, Beñat ^a   Higuera Matas, Alejandro ^c   Lopez Parra, Virginia ^a   Ortiz Muñoz, Guadalupe ^a   Ambrosio, Emilio ^b   Egido, Jesus ^a   Almeida, Osborne F X ^a   Gomez Guerrero, Carmen ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c UNIVERSIDAD NACIONAL DE EDUCACIÓN A DISTANCIA   (Spain)

Author keywords

Alzheimer's disease; apolipoprotein E; cognitive dysfunction; hypercholesterolaemia; immunoglobulin receptors

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; FC RECEPTOR; IMMUNOGLOBULIN G; MITOGEN ACTIVATED PROTEIN KINASE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; GENE DELETION; HIPPOCAMPUS; HYPERCHOLESTEROLEMIA; IN VITRO STUDY; LEARNING DISORDER; MEMORY DISORDER; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SYNAPSE; UPREGULATION;

EID: 84866411198     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aws195     Document Type: Article

References (63)

1. Ashe KH, Zahs KR. Probing the biology of Alzheimer's disease in mice. Neuron 2010; 66: 631-45.
2. Bake S, Friedman JA, Sohrabji F. Reproductive age-related changes in the blood brain barrier: expression of IgG and tight junction proteins. Microvasc Res 2009; 78: 413-24.
3. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer's disease. Lancet 2011; 377: 1019-31.
4. Barnes J, Godbolt AK, Frost C, Boyes RG, Jones BF, Scahill RI, et al. Atrophy rates of the cingulate gyrus and hippocampus in Alzheimer's disease and FTLD. Neurobiol Aging 2007; 28: 20-28.
5. Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, et al. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 2010; 68: 409-27.
6. Bertram L, Lill CM, Tanzi RE. The genetics of Alzheimer disease: back to the future. Neuron 2010; 68: 270-81.
7. Bjelik A, Bereczki E, Gonda S, Juhász A, Rimanó czy A, Zana M, et al. Human apoB overexpression and a high-cholesterol diet differently modify the brain APP metabolism in the transgenic mouse model of atherosclerosis. Neurochem Int 2006; 49: 393-400.
8. Bouras C, Riederer BM, Kovari E, Hof PR, Giannakopoulos P. Humoral immunity in brain aging and Alzheimer's disease. Brain Res Brain Res Rev 2005; 48: 477-87.
9. Burut DF, Karim Y, Ferns GA. The role of immune complexes in athero-genesis. Angiology 2010; 61: 679-89.
10. Carvalho-Filho RJ, Narciso-Schiavon JL, Tolentino LH, Schiavon LL, Ferraz ML, Silva AE. Central nervous system vasculitis and polyneur-opathy as first manifestations of hepatitis C. World J Gastroenterol 2012; 18: 188-91.
11. Colucci-D'Amato L, Perrone-Capano C, di PU. Chronic activation of ERK and neurodegenerative diseases. Bioessays 2003; 25: 1085-95.
12. Crisby M, Rahman SM, Sylven C, Winblad B, Schultzberg M. Effects of high cholesterol diet on gliosis in apolipoprotein E knockout mice. Implications for Alzheimer's disease and stroke. Neurosci Lett 2004; 369: 87-92.
13. Curtis J, Finkbeiner S. Sending signals from the synapse to the nucleus: possible roles for CaMK, Ras/ERK, and SAPK pathways in the regulation of synaptic plasticity and neuronal growth. J Neurosci Res 1999; 58: 88-95.
14. Diamond B, Huerta PT, Mina-Osorio P, Kowal C, Volpe BT. Losing your nerves? Maybe it's the antibodies. Nat Rev Immunol 2009; 9: 449-56.
15. Doyle HA, Mamula MJ. Post-translational protein modifications in antigen recognition and autoimmunity. Trends Immunol 2001; 22: 443-9.
16. Eichenbaum H, Yonelinas AP, Ranganath C. The medial temporal lobe and recognition memory. Annu Rev Neurosci 2007; 30: 123-52.
17. Ferná ndez-Vizarra P, Fernández AP, Castro-Blanco S, Serrano J, Bentura ML, Martínez-Murillo R, et al. Intra-and extracellular Abeta and PHF in clinically evaluated cases of Alzheimer's disease. Histol Histopathol 2004; 19: 823-44.
18. Gomez RM, Rosso OA, Berretta R, Moscato P. Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease. PLoS One 2010; 5: e10153.
19. Gordon I, Genis I, Grauer E, Sehayek E, Michaelson DM. Biochemical and cognitive studies of apolipoprotein-E-deficient mice. Mol Chem Neuropathol 1996; 28: 97-103.
20. Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F, et al. Intraneuronal Abeta42 accumulation in human brain. Am J Pathol 2000; 156: 15-20.
21. Gyure KA, Durham R, Stewart WF, Smialek JE, Troncoso JC. Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome. Arch Pathol Lab Med 2001; 125: 489-92.
22. Hafezi-Moghadam A, Thomas KL, Wagner DD. ApoE deficiency leads to a progressive age dependent blood-brain barrier leakage. Am J Physiol Cell Physiol 2007; 292: C1256-62.
23. Hardy J. Has the amyloid cascade hypothesis for Alzheimer's disease been proved? Curr Alzheimer Res 2006; 3: 71-3.
24. Haroun M, El-Sayed M. Measurement of IgG levels can serve as a bio-marker in newly diagnosed diabetic children. J Clin Biochem Nutr 2007; 40: 56-61.
25. Harris PS, Cobbs CG. Cardiac, cerebral, and vascular complications of infective endocarditis. Cardiol Clin 1996; 14: 437-50.
26. Hernandez-Vargas P, Ortiz-Muñoz G, Lopez-Franco O, Suzuki Y, Gallego-Delgado J, Sanjuan G, et al. Fcgamma receptor deficiency confers protection against atherosclerosis in apolipoprotein E knockout mice. Circ Res 2006; 99: 1188-96.
27. Jin S, Agerman K, Kolmodin K, Gustafsson E, Dahlqvist C, Jureus A, et al. Evidence for dimeric BACE-mediated APP processing. Biochem Biophys Res Commun 2010; 393: 21-7.
28. Kuang F, Wang BR, Zhang P, Fei LL, Jia Y, Duan XL, et al. Extravasation of blood-borne immunoglobulin G through blood-brain barrier during adrenaline-induced transient hypertension in the rat. Int J Neurosci 2004; 114: 575-91.
29. Li R, Lindholm K, Yang LB, Yue X, Citron M, Yan R, et al. Amyloid beta peptide load is correlated with increased betasecretase activity in sporadic Alzheimer's disease patients. Proc Natl Acad Sci USA 2004; 101: 3632-7.
30. Lister KJ, Hickey MJ. Immune complexes alter cerebral microvessel permeability: roles of complement and leukocyte adhesion. Am J Physiol Heart Circ Physiol 2006; 291: H694-704.
31. Listì F, Candore G, Modica MA, Russo M, Di Lorenzo G, Esposito-Pellitteri M, et al. A study of serum immunoglobulin levels in elderly persons that provides new insights into B cell immunosenescence. Ann N Y Acad Sci 2006; 1089: 487-95.
32. Lu J, Moochhala S, Kaur C, Ling EA. Cellular inflammatory response associated with breakdown of the blood-brain barrier after closed head injury in rats. J Neurotrauma 2001; 18: 399-408.
33. Luo Y, Pollard JW, Casadevall A. Fcgamma receptor cross-linking stimulates cell proliferation of macrophages via the ERK pathway. J Biol Chem 2010; 285: 4232-42.
34. Masliah E, Mallory M, Alford M, DeTeresa R, Hansen LA, McKeel DW Jr, et al. Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology 2001; 56: 127-9.
35. Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, et al. Decreased clearance of CNS beta-amyloid in Alzheimer's disease. Science 2010; 330: 1774.
36. Methia N, Andre P, Hafezi-Moghadam A, Economopoulos M, Thomas KL, Wagner DD. ApoE deficiency compromises the blood brain barrier especially after injury. Mol Med 2001; 7: 810-5.
37. Morrison JH, Hof PR. Selective vulnerability of corticocortical and hippo-campal circuits in aging and Alzheimer's disease. Prog Brain Res 2002; 136: 467-86.
38. Murai T, Okuda S, Tanaka T, Ohta H. Characteristics of object location memory in mice: Behavioral and pharmacological studies. Physiol Behav 2007; 90: 116-24.
39. Nakahara J, Tan-Takeuchi K, Seiwa C, Gotoh M, Kaifu T, Ujike A, et al. Signaling via immunoglobulin Fc receptors induces oligodendrocyte precursor cell differentiation. Dev Cell 2003; 4: 841-52.
40. Nakata A, Araki S, Tanigawa T, Miki A, Sakurai S, Kawakami N, et al. Decrease of suppressor-inducer (CD4+ CD45RA) T lymphocytes and increase of serum immunoglobulin G due to perceived job stress in Japanese nuclear electric power plant workers. J Occup Environ Med 2000; 42: 143-50.
41. Nimmerjahn F, Bruhns P, Horiuchi K, Ravetch JV. FcgammaRIV: a novel FcR with distinct IgG subclass specificity. Immunity 2005; 23: 41-51.
42. Nimmerjahn F, Ravetch JV. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 2008; 8: 34-47.
43. Oitzl MS, Mulder M, Lucassen PJ, Havekes LM, Grootendorst J, de Kloet ER. Severe learning deficits in apolipoprotein E-knockout mice in a water maze task. Brain Res 1997; 752: 189-96.
44. Okamatsu Y, Matsuda K, Hiramoto I, Tani H, Kimura K, Yada Y, et al. Ghrelin and leptin modulate immunity and liver function in overweight children. Pediatr Int 2009; 51: 9-13.
45. Oreskes I, Mandel D. Size fractionation of thermal aggregates of im-munoglobulin G. Anal Biochem 1983; 134: 199-204.
46. Ortiz-Muñoz G, Lopez-Parra V, Lopez-Franco O, Fernandez-Vizarra P, Mallavia B, Flores C, et al. Suppressors of cytokine signalling abrogate diabetic nephropathy. J Am Soc Nephrol 2010; 21: 763-72.
47. Ounanian A, Guilbert B, Renversez JC, Seigneurin JM, Avrameas S. Antibodies to viral antigens, xenoantigens, and autoantigens in Alzheimer's disease. J Clin Lab Anal 1990; 4: 367-75.
48. Pengas G, Hodges JR, Watson P, Nestor PJ. Focal posterior cingulate atrophy in incipient Alzheimer's disease. Neurobiol Aging 2010; 31: 25-33.
49. Rahman A, Akterin S, Flores-Morales A, Crisby M, Kivipelto M, Schultzberg M, et al. High cholesterol diet induces tau hyperphosphor-ylation in apolipoprotein E deficient mice. FEBS Lett 2005; 579: 6411-16.
50. Reddy PH, Mani G, Park BS, Jacques J, Murdoch G, Whetsell W Jr, et al. Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction. J Alzheimers Dis 2005; 7: 103-17.
51. Rodrigo J, Ferná ndez-Vizarra P, Castro-Blanco S, Bentura ML, Nieto M, Gómez-Isla T, et al. Nitric oxide in the cerebral cortex of amyloid-precursor protein (SW) Tg2576 transgenic mice. Neuroscience 2004; 128: 73-89.
52. Sato S, Tatebayashi Y, Akagi T, Chui DH, Murayama M, Miyasaka T, et al. Aberrant tau phosphorylation by glycogen synthase kinase-3beta and JNK3 induces oligomeric tau fibrils in COS-7 cells. J Biol Chem 2002; 277: 42060-5.
53. Schmechel A, Strauss M, Schlicksupp A, Pipkorn R, Haass C, Bayer TA, et al. Human BACE forms dimers and colocalizes with APP. J Biol Chem 2004; 279: 39710-7.
54. Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001; 81: 741-66.
55. Shepardson NE, Shankar GM, Selkoe DJ. Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies. Arch Neurol 2011a; 68: 1239-44.
56. Shepardson NE, Shankar GM, Selkoe DJ. Cholesterol level and statin use in Alzheimer Disease: II. Review of human trials and recommendations. Arch Neurol 2011b; 68: 1385-92.
57. Song X, Shapiro S, Goldman DL, Casadevall A, Scharff M, Lee SC. Fcgamma receptor I-and III-mediated macrophage inflammatory protein 1alpha induction in primary human and murine microglia. Infect Immun 2002; 70: 5177-84.
58. Turk Z, Ljubic S, Turk N, Benko B. Detection of autoantibodies against advanced glycation endproducts and AGE-immune complexes in serum of patients with diabetes mellitus. Clin Chim Acta 2001; 303: 105-15.
59. Veinbergs I, Mante M, Jung MW, Van UE, Masliah E. Synaptotagmin and synaptic transmission alterations in apolipoprotein E-deficient mice. Prog Neuropsychopharmacol Biol Psychiatry 1999; 23: 519-31.
60. Walter J, Fluhrer R, Hartung B, Willem M, Kaether C, Capell A, et al. Phosphorylation regulates intracellular trafficking of betasecretase. J Biol Chem 2001; 276: 14634-41.
61. Winer DA, Winer S, Shen L, Wadia PP, Yantha J, Paltser G, et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med 2011; 17: 610-17.
62. Yang LB, Lindholm K, Yan R, Citron M, Xia W, Yang XL, et al. Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat Med 2003; 9: 3-4.
63. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hyperchol-esterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992; 258: 468-71.